Evolution of the concept of focal therapy for prostate cancer

ONCOLOGY (United States)

Volumn 27, Issue 1, 2013, Pages

  Tsivian, Matvey ^a   Abern, Michael R ^a   Polascik, Thomas J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ACOUSTIC RADIATION FORCE IMPULSE IMAGING; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER THERAPY; CLINICAL TRIAL (TOPIC); DISEASE SURVEILLANCE; ECHOGRAPHY; ELASTOGRAPHY; ENTEROPATHY; HUMAN; MINIMALLY INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; REVIEW; TREATMENT OUTCOME; URINE INCONTINENCE; WATCHFUL WAITING;

EID: 84874615181     PISSN: 08909091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (27)

1. de la Rosette J, Ahmed H, Barentsz J, et al. Focal therapy in prostate cancerreport from a consensus panel. J Endourol. 2010;24:775-80.
2. Tsivian M, Polascik TJ. Prostate cancer: ideal candidates for focal therapy. Nat Rev Urol. 2012;9:12,13.
3. Marberger M, Barentsz J, Emberton M, et al. Novel approaches to improve prostate cancer diagnosis and management in early-stage disease. BJU Int. 2012;109(Suppl 2):1-7.
4. Wilt TJ, Brawer MK, Jones KM, et al. Radical prostatectomy versus observation for localized prostate cancer. N Engl J Med. 2012;367:203-13.
5. Wu GH, Auvinen A, Maattanen L, et al. Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening. Int J Cancer. 2012;131:1367-75.
6. Kapoor DA, Zimberg SH, Ohrin LM, et al. Utilization trends in prostate cancer therapy. J Urol. 2011; 186:860-4.
7. Namiki S, Arai Y. Health-related quality of life in men with localized prostate cancer. Int J Urol. 2010;17: 125-38.
8. Bahn D, de Castro Abreu AL, Gill IS, et al. Focal cryotherapy for clinically unilateral, low-intermediate risk prostate cancer in 73 men with a median follow-up of 3.7 years. Eur Urol. 2012;62:55-63.
9. Ahmed HU, Hindley RG, Dickinson L, et al. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study. Lancet Oncol. 2012;13:622-32.
10. Tsivian M, Polascik TJ. Focal cryotherapy for prostate cancer. Curr Urol Rep. 2010;11:147-151.
11. Klotz L, Zhang L, Lam A, et al. Clinical results of long-term follow-up of a large, active surveillance cohort with localized prostate cancer. J Clin Oncol. 2010;28:126-31.
12. Abern MR, Tsivian M, Polascik TJ. Focal therapy of prostate cancer: evidence-based analysis for modern selection criteria. Curr Urol Rep. 2012;13:160-9.
13. Ahmed HU. The index lesion and the origin of prostate cancer. N Engl J Med. 2009;361:1704-6.
14. Gulati R, Wever EM, Tsodikov A, et al. What if I dont treat my PSA-detected prostate cancer? Answers from three natural history models. Cancer Epidemiol Biomarkers Prev. 2011;20:740-50.
15. Waitz R, Solomon SB, Petre EN, et al. Potent induction of tumor immunity by combining tumor cryoablation with anti-CTLA-4 therapy. Cancer Res. 2012;72:430-9.
16. Si T, Guo Z, Hao X. Immunologic response to primary cryoablation of high-risk prostate cancer. Cryobiology. 2008;57:66-71.
17. Dallera MA, Albertsen PC, Bangma C, et al. Active surveillance for prostate cancer: a systematic review of the literature. Eur Urol 2012;62:976-83.
18. Palisaar JR, Noldus J, Loppenberg B, et al. Comprehensive report on prostate cancer misclassification by 16 currently used low-risk and active surveillance criteria. BJU Int. 2012;110:E172-81
19. Smeenge M, de la Rosette JJ, Wijkstra H. Current status of transrectal ultrasound techniques in prostate cancer. Curr Opin Urol. 2012;22:297-302.
20. Palmeri ML, Nightingale KR. Acoustic radiation force-based elasticity imaging methods. Interface Focus. 2011;1:553-64.
21. Hoang AN, Volkin D, Yerram NK, et al. Image guidance in the focal treatment of prostate cancer. Curr Opin Urol. 2012;22:328-35.
22. Dickinson L, Ahmed HU, Allen C, et al. Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. Eur Urol. 2011;59:477-94.
23. Margel D, Yap SA, Lawrentschuk N, et al. Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: a prospective cohort study. J Urol. 2012;187:1247-52.
24. Lambert EH, Bolte K, Masson P, Katz AE. Focal cryosurgery: encouraging health outcomes for unifocal prostate cancer. Urology. 2007; 69:1117-20.
25. Onik G, Vaughan D, Lotenfoe R, et al. Male lumpectomy: focal therapy for prostate cancer using cryoablation. Urology. 2007;70(6 Suppl):16-21.
26. Ahmed HU, Freeman A, Kirkham A, et al. Focal therapy for localized prostate cancer: a phase I/II trial. J Urol. 2011;185:1246-54.
27. El Fegoun AB, Barret E, Prapotnich D, et al. Focal therapy with high-intensity focused ultrasound for prostate cancer in the elderly. A feasibility study with 10 years follow-up. Int Braz J Urol. 2011;37:213-19.